Li Feina, Xiao Jing, Yang Haiming, Yao Yao, Li Jieqiong, Zheng Huiwen, Guo Qian, Wang Xiaotong, Chen Yuying, Guo Yajie, Wang Yonghong, Shen Chen
Laboratory of Respiratory Diseases, Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China.
Department of Respiratory Diseases II, Beijing Children's Hospital, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Capital Medical University, Beijing, China.
Front Microbiol. 2022 Mar 15;13:858806. doi: 10.3389/fmicb.2022.858806. eCollection 2022.
(MP) is a one of most common pathogen in causing respiratory infection in children and adolescents. Rapid and efficient diagnostic methods are crucial for control and treatment of MP infections. Herein, we present an operationally simple, rapid and efficient molecular method for MP identification, which eliminates expensive instruments and specialized personnel. The method combines recombinase polymerase amplification (RPA) with clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated proteins (Cas) 12a-based detection, with an optimal procedure less than 1 h from sample to result including DNA extraction (25 min), RPA reaction (39°C for 15-20 min), CRISPR/Cas12a detection (37°C for 10 min) and visual detection by naked eyes (2 min). This diagnostic method shows high sensitivity (two copies per reaction) and no cross-reactivity against other common pathogenic bacteria. Preliminary evaluation using 201 clinical samples shows sensitivity of 99.1% (107/108), specificity of 100% (93/93) and consistency of 99.5% (200/201), compared with real-time PCR method. The above data demonstrate that our developed method is reliable for rapid diagnosis of MP. In conclusion, the RPA-CRISPR/Cas12a has a great potential to be as a useful tool for reliable and quick diagnosis of MP infection, especially in primary hospitals with limited conditions.
肺炎支原体(MP)是引起儿童和青少年呼吸道感染最常见的病原体之一。快速有效的诊断方法对于MP感染的控制和治疗至关重要。在此,我们提出一种操作简单、快速高效的MP鉴定分子方法,该方法无需昂贵仪器和专业人员。该方法将重组酶聚合酶扩增(RPA)与基于成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关蛋白(Cas)12a的检测相结合,从样本到结果的最佳流程少于1小时,包括DNA提取(25分钟)、RPA反应(39°C 15 - 20分钟)、CRISPR/Cas12a检测(37°C 10分钟)和肉眼视觉检测(2分钟)。这种诊断方法显示出高灵敏度(每个反应两个拷贝),且对其他常见病原菌无交叉反应。与实时PCR方法相比,使用201份临床样本进行的初步评估显示灵敏度为99.1%(107/108),特异性为100%(93/93),一致性为99.5%(200/201)。上述数据表明,我们开发的方法对于MP的快速诊断是可靠的。总之,RPA - CRISPR/Cas12a有很大潜力成为可靠快速诊断MP感染的有用工具,尤其是在条件有限的基层医院。